Clinical Trial Results:
A Phase II Open Label Study of CB7630 (Abiraterone Acetate) and Prednisone in
Patients with Advanced Prostate Cancer Who Have Failed Androgen Deprivation and
Docetaxel-Based Chemotherapy
Summary
|
|
EudraCT number |
2007-002725-74 |
Trial protocol |
GB |
Global completion date |
04 Oct 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 Nov 2016
|
First version publication date |
10 Nov 2016
|
Other versions |
|
Summary report(s) |
2007-002725-74_COU-AA-004_CT.gov results. |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.